Vanda Pharmaceuticals Inc (VNDA) - Financial and Strategic SWOT Analysis Review

Vanda Pharmaceuticals Inc (VNDA) - Financial and Strategic SWOT Analysis Review


  • Products Id :- GDPH140528FSA
  • |
  • Pages: 42
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Vanda Pharmaceuticals Inc (VNDA)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Vanda Pharmaceuticals Inc (Vanda Pharmaceuticals) is a specialty pharmaceutical company that develops and commercializesnovel therapies for the treatment of central nervous system disorders. The company's products include Hetlioz, a melatonin receptor agonist for the treatment of non-24-hour sleep-wake disorder; and Fanapt, an atypical antipsychotic for the treatment of schizophrenia in adults. Its pipeline portfolio includes Tradipitant (VLY-686), a small molecule neurokinin-1 receptor antagonist for pruritus in atopic dermatitis; VQW-765 (formerly AQW-051), an alpha-7 nicotinic acetylcholine receptor for CNS disorders; and VTR-297 (formerly Trichostatin A) for oncology indications. Vanda Pharmaceuticals is headquartered in Washington DC, the US.

Vanda Pharmaceuticals Inc Key Recent Developments

May 02,2018: Vanda Pharmaceuticals Reports First Quarter 2018 Financial Results

Feb 14,2018: Vanda Pharmaceuticals Reports Fourth Quarter 2017 Financial Results

Jan 07,2018: Vanda Pharmaceuticals Reports Preliminary Fourth Quarter and Full Year 2017 Revenue Results and 2018 Guidance

Nov 07,2017: Vanda Pharmaceuticals Reports Third Quarter 2017 Financial Results

Aug 02,2017: Vanda Pharmaceuticals Reports Second Quarter 2017 Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Section 1-About the Company 6

Vanda Pharmaceuticals Inc-Key Facts 6

Vanda Pharmaceuticals Inc-Key Employees 7

Vanda Pharmaceuticals Inc-Key Employee Biographies 8

Vanda Pharmaceuticals Inc-Major Products and Services 9

Vanda Pharmaceuticals Inc-History 10

Vanda Pharmaceuticals Inc-Company Statement 11

Vanda Pharmaceuticals Inc-Locations And Subsidiaries 12

Head Office 12

Other Locations & Subsidiaries 12

Section 2-Company Analysis 13

Company Overview 13

Vanda Pharmaceuticals Inc-Business Description 14

Product Category: Fanapt 14

Overview 14

Performance 14

Product Category: HETLIOZ 14

Overview 14

Performance 14

R&D Overview 14

Vanda Pharmaceuticals Inc-Corporate Strategy 15

Vanda Pharmaceuticals Inc-SWOT Analysis 16

SWOT Analysis-Overview 16

Vanda Pharmaceuticals Inc-Strengths 16

Vanda Pharmaceuticals Inc-Weaknesses 17

Vanda Pharmaceuticals Inc-Opportunities 18

Vanda Pharmaceuticals Inc-Threats 19

Vanda Pharmaceuticals Inc-Key Competitors 20

Section 3-Company Financial Ratios 21

Financial Ratios-Capital Market Ratios 21

Financial Ratios-Annual Ratios 22

Performance Chart 25

Financial Performance 25

Financial Ratios-Interim Ratios 26

Financial Ratios-Ratio Charts 27

Section 4-Company's Lifesciences Financial Deals and Alliances 28

Vanda Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 28

Vanda Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 29

Vanda Pharmaceuticals Inc, Recent Deals Summary 30

Section 5-Company's Recent Developments 31

May 02, 2018: Vanda Pharmaceuticals Reports First Quarter 2018 Financial Results 31

Jan 07, 2018: Vanda Pharmaceuticals Reports Preliminary Fourth Quarter and Full Year 2017 Revenue Results and 2018 Guidance 32

Nov 07, 2017: Vanda Pharmaceuticals Reports Third Quarter 2017 Financial Results 33

Aug 02, 2017: Vanda Pharmaceuticals Reports Second Quarter 2017 Financial Results 34

May 02, 2017: Vanda Pharmaceuticals Reports First Quarter 2017 Financial Results 35

Feb 15, 2017: Vanda Pharmaceuticals Reports Fourth Quarter 2016 and Full Year 2016 Financial Results 36

Jan 09, 2017: Vanda Pharmaceuticals Reports Preliminary Fourth Quarter and Full Year 2016 Revenue Results and 2017 Financial Guidance 37

Section 6-Appendix 38

Methodology 38

Ratio Definitions 38

About GlobalData 42

Contact Us 42

Disclaimer 42

List of Figures

Vanda Pharmaceuticals Inc, Performance Chart (2013-2017) 25

Vanda Pharmaceuticals Inc, Ratio Charts 27

Vanda Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 28

Vanda Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 29

List of Tables

Vanda Pharmaceuticals Inc, Key Facts 6

Vanda Pharmaceuticals Inc, Key Employees 7

Vanda Pharmaceuticals Inc, Key Employee Biographies 8

Vanda Pharmaceuticals Inc, Major Products and Services 9

Vanda Pharmaceuticals Inc, History 10

Vanda Pharmaceuticals Inc, Subsidiaries 12

Vanda Pharmaceuticals Inc, Key Competitors 20

Vanda Pharmaceuticals Inc, Ratios based on current share price 21

Vanda Pharmaceuticals Inc, Annual Ratios 22

Vanda Pharmaceuticals Inc, Annual Ratios (Cont...1) 23

Vanda Pharmaceuticals Inc, Annual Ratios (Cont...2) 24

Vanda Pharmaceuticals Inc, Interim Ratios 26

Vanda Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 28

Vanda Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 29

Vanda Pharmaceuticals Inc, Recent Deals Summary 30

Currency Codes 38

Capital Market Ratios 38

Equity Ratios 39

Profitability Ratios 39

Cost Ratios 40

Liquidity Ratios 40

Leverage Ratios 41

Efficiency Ratios 41

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Teva Pharmaceutical Industries Ltd

Takeda Pharmaceutical Co Ltd

Sunovion Pharmaceuticals Inc

Sanofi

Pfizer Inc

Pernix Therapeutics Holdings Inc

Neurim Pharmaceuticals Ltd

Merck & Co Inc

Les Laboratoires Servier SAS

Allergan Plc

Vanda Pharmaceuticals Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts

select a license
Single User License
USD 125 INR 8924
Site License
USD 250 INR 17848
Corporate User License
USD 375 INR 26771

NEWSLETTER BY CATEGORY




Testimonials

The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com